InvAscent

Premium
How InvAscent valued bulk-drugs maker in latest twin deals

Healthcare

30 July, 2026

How InvAscent valued bulk-drugs maker in latest twin deals

Healthcare-focused private equity firm InvAscent is investing in the bulk-drugs subsidiary of a Mumbai-listed company to......

Premium

Healthcare

08 July, 2026

Bottomline: PE-backed Inventia Healthcare returns to growth, turns net cash positive in FY26

Mumbai-based Inventia Healthcare Ltd, a drug development and manufacturing company backed by US-based buyout firm ......

Premium

Healthcare

20 February, 2026

Bottomline: PE-controlled Maiva Pharma faces headwinds amid project delays

Sterile injectables manufacturer Maiva Pharma Pvt Ltd, jointly controlled by Morgan Stanley Private Equity Asia and ......

Premium

Healthcare

27 January, 2026

Punjab's Deep Hospital explores first external fundraise, hires banker

Deep Hospital, a multispecialty healthcare centre in Punjab, is exploring its first external fundraise and has appointed......

Premium

General

22 January, 2026

Grapevine: Blackstone, Actis, InvAscent in news

Blackstone is evaluating an initial public offering (IPO) for glass packaging manufacturer PGP Glass, while UK‑based ......

Premium

Healthcare

30 December, 2025

Bottomline: InvAscent-backed Malladi Drugs' FY25 revenue, profit fall amid IPO plans

InvAscent-backed bulk drugs maker Malladi Drugs and Pharmaceuticals Ltd reported a decline in both revenue and net ......

Premium

Healthcare

04 November, 2025

Bottomline: PE-backed Sharp Sight polishes metrics ahead of potential merger, investor exit

Eye-care chain Sharp Sight Group of Eye Hospitals, which is in merger talks with ASG Eye Hospitals in a deal ......

Premium

General

03 October, 2025

Deals Digest: PE/VC activity slows but M&A value jumps on a jumbo transaction

Private equity and venture capital investments fell during the five-day period ending Friday from the week before but ......

Premium

Finance

02 May, 2025

InvAscent marks final close of fourth PE fund, falls shy of target

Healthcare-focused private equity firm InvAscent has marked the final close of its fourth fund that was floated in mid-......

Premium

Healthcare

14 April, 2025

InvAscent looks to log another exit from pharma portfolio

Healthcare-focused private equity firm InvAscent is looking to exit its more than six-year-old investment in an animal ......

Most Popular

Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News